KK
PRME icon

KLP Kapitalforvaltning’s Prime Medicine PRME Stock Holding History

KLP Kapitalforvaltning’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.3K Hold
18,500
– – ﹤0.01% 2117
2026
Q1 		$64.4K Hold
18,500
– – ﹤0.01% 2117
2025
Q4 		$64.2K Buy
+18,500
New +$82.3K ﹤0.01% 2131

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

KLP Kapitalforvaltning's PRME Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Prime Medicine (PRME) position steady in Q2 2026 at 18,500 shares worth $68.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

KLP Kapitalforvaltning first reported a position in PRME in Q4 2025 and has held it in 3 quarters since. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • KLP Kapitalforvaltning held 18,500 shares of Prime Medicine worth $68.3K as of Q2 2026.
  • KLP Kapitalforvaltning left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2117 holding.
  • KLP Kapitalforvaltning first reported a position in Prime Medicine in Q4 2025 and has held it in 3 quarters since.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.